Abstract
The presence of Helicobacter pylori in the gastroduodenal mucosae is associated with chronic active gastritis, peptic ulcers and gastric cancers such as adenocarcinoma and low-grade gastric B-cell lymphoma. In response to the presence of antibiotic-resistant strains, the use of vaccines to combat this infection has become an attractive alternative. The present study used a murine model of infection by a mouse-adapted H. pylori strain to determine whether infection in BALB/c mice can be successfully eradicated by intragastric vaccination with H. pylori heparan sulphate-binding proteins (HSBP) covalently coupled to the beta-subunit of cholera toxin (CTB). It was shown that vaccination confers protection against exposure of BALB/c mice to the pathogen, as revealed by microbiological, histopathological and molecular methods.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Administration, Oral
-
Animals
-
Antibodies, Bacterial / blood
-
Bacterial Vaccines* / administration & dosage
-
Bile / immunology
-
Blood Coagulation Factors*
-
Carrier Proteins / immunology*
-
Carrier Proteins / metabolism
-
Cholera Toxin / immunology*
-
Cholera Toxin / metabolism
-
DNA, Bacterial / analysis
-
Disease Models, Animal
-
Gastric Mucosa / immunology
-
Gastric Mucosa / microbiology
-
Helicobacter Infections / prevention & control*
-
Helicobacter pylori / genetics
-
Helicobacter pylori / immunology*
-
Helicobacter pylori / isolation & purification
-
Heparin / metabolism
-
Immunity, Mucosal
-
Immunization / methods
-
Immunoglobulin A / analysis
-
Immunoglobulin A / blood
-
Immunoglobulin G / blood
-
Mice
-
Mice, Inbred BALB C
-
Polymerase Chain Reaction
-
RNA-Binding Proteins
-
Ribosomal Proteins
-
Vaccines, Conjugate / administration & dosage
Substances
-
Antibodies, Bacterial
-
Bacterial Vaccines
-
Blood Coagulation Factors
-
Carrier Proteins
-
DNA, Bacterial
-
Immunoglobulin A
-
Immunoglobulin G
-
RNA-Binding Proteins
-
RPL29 protein, human
-
Ribosomal Proteins
-
Vaccines, Conjugate
-
Heparin
-
Cholera Toxin